Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-029910

SVP, Chief Business Officer acquired 37,120 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Davis Andrew SVP, Chief Business Officer 2024-03-08 Option exercise +37,120 310,756 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Davis Andrew SVP, Chief Business Officer 2024-03-08 Option exercise · Performance-based Restricted Stock Unit −37,120 0 D: show line 2 in the form
Loading xslF345X05/ownership.xml…